| Identification | Back Directory | [Name]
Farglitazar | [CAS]
196808-45-4 | [Synonyms]
G1 262570
GI 262570
GI 262570X
Farglitazar
N-(2-Benzoylphenyl)-O-[2-(5-methyl-2-phenyl-4-oxazolyl)ethyl]-L-tyrosine
L-Tyrosine, N-(2-benzoylphenyl)-O-[2-(5-methyl-2-phenyl-4-oxazolyl)ethyl]-
2(S)-(2-Benzoylphenylamino)-3-[4-[2-(5-methyl-2-phenyloxazol-4-yl)ethoxy]phenyl]propionic acid
(S)-2-((2-Benzoylphenyl)amino)-3-(4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)propanoic acid | [Molecular Formula]
C34H30N2O5 | [MDL Number]
MFCD07364057 | [MOL File]
196808-45-4.mol | [Molecular Weight]
546.61 |
| Chemical Properties | Back Directory | [Melting point ]
148-150 °C | [Boiling point ]
793.7±70.0 °C(Predicted) | [density ]
1.257±0.06 g/cm3(Predicted) | [form ]
Solid | [pka]
3.91±0.10(Predicted) | [color ]
White to yellow |
| Hazard Information | Back Directory | [Uses]
Farglitazar is a peroxisome proliferator-activated receptor (PPAR) agonist and has been explored for treating hepatic fibrosis and type 2 diabetes. | [Uses]
Treatment of Type II diabetes (insulin action enhancer). |
|
| Company Name: |
Energy Chemical
|
| Tel: |
021-58432009 400-005-6266 |
| Website: |
http://www.energy-chemical.com |
|